Literature DB >> 8738128

Immunohistochemical localization of insulin-like growth factor binding protein-5 in the developing rat nervous system.

H L Cheng1, K A Sullivan, E L Feldman.   

Abstract

The insulin-like growth factors (IGF-I and IGF-II) are peptides with both growth-promoting and insulin-like metabolic effects. The IGFs interact with and are modulated by a group of six IGF-binding proteins (IGFBP-1 through IGFBP-6). Previous studies have characterized IGFBP-5 and IGF-I gene expression in the developing nervous system. In the current study, cellular and tissue-specific distribution of IGFBP-5 protein was examined in the developing rodent nervous system using immunohistochemistry. Beginning with embryonic stage E12, IGFBP-5 immunoreactivity was observed in peripheral nerves. This pattern persisted through adulthood and was detected within Schwann cells and axons after postnatal day 16 (P16). IGFBP-5 immunoreactivity first appeared in the CNS at P16. Purkinje cells of the cerebellum were immunostained at P16, P32 and in the adult. IGFBP-5 immunoreactivity was also detected in several brain stem nuclei and their corresponding tracts as well as neuroglia. Nerve tracts and glia in the postnatal spinal cord were also immunopositive, however, spinal cord neurons were not stained. The current results, coupled with the known profile of IGF-I expression during nervous system development demonstrates the colocalization of IGF-I and IGFBP-5 in PNS, cerebellum, and brain stem.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738128     DOI: 10.1016/0165-3806(96)00016-8

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

1.  Peripheral nervous system maturation in preterm infants: longitudinal motor and sensory nerve conduction studies.

Authors:  S Lori; Giovanna Bertini; M Bastianelli; S Gabbanini; D Gualandi; E Molesti; C Dani
Journal:  Childs Nerv Syst       Date:  2018-04-10       Impact factor: 1.475

2.  Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems.

Authors:  S S Oh; K A Sullivan; J E Wilkinson; C Backus; J M Hayes; S A Sakowski; E L Feldman
Journal:  Neuroscience       Date:  2012-04-16       Impact factor: 3.590

3.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Authors:  Andrea M Vincent; Koichi Kato; Lisa L McLean; Mary E Soules; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 4.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

5.  Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

Authors:  Ann-Christin Sandberg Nordqvist; Tiit Mathiesen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

6.  Mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; John M Hayes; Timothy D Wiggin; Carey Backus; Sang Su Oh; Stephen I Lentz; Frank Brosius; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2007-07-31       Impact factor: 5.996

7.  Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn.

Authors:  H T Cheng; M Suzuki; D M Hegarty; Q Xu; A R Weyerbacher; S M South; M Ohata; C E Inturrisi
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

8.  Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.

Authors:  Christian M Simon; Stefanie Rauskolb; Jennifer M Gunnersen; Bettina Holtmann; Carsten Drepper; Benjamin Dombert; Massimiliano Braga; Stefan Wiese; Sibylle Jablonka; Dirk Pühringer; Jürgen Zielasek; Andreas Hoeflich; Vincenzo Silani; Eckhard Wolf; Susanne Kneitz; Claudia Sommer; Klaus V Toyka; Michael Sendtner
Journal:  Acta Neuropathol       Date:  2015-05-30       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.